Blood test breakthrough predicts pancreatic cancer survival
NCT ID NCT07329920
Summary
This study looked back at 300 pancreatic cancer patients to see if a blood test could help predict their outcomes. The test measures changes in cancer cells circulating in the blood, especially during pre-surgery treatment. Researchers found that tracking these cell changes could help doctors assess how well a patient is responding to therapy and predict their chances of survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital of Naval Medical UniversityUniversity
Shanghai, Shanghai Municipality, 200433, China
Conditions
Explore the condition pages connected to this study.